InterCure Ltd. (INCR)
INCR Stock Price Chart
Explore InterCure Ltd. interactive price chart. Choose custom timeframes to analyze INCR price movements and trends.
INCR Company Profile
Discover essential business fundamentals and corporate details for InterCure Ltd. (INCR) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
28 Jan 2019
Employees
320.00
Website
https://www.intercure.coCEO
Alexander Rabinovich
Description
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.
INCR Financial Timeline
Browse a chronological timeline of InterCure Ltd. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 29 Apr 2026
Earnings released on 28 Aug 2025
Earnings released on 20 Aug 2025
EPS came in at -$0.00 , while revenue for the quarter reached $19.42m , meeting expectations.
Earnings released on 1 May 2025
EPS came in at -$0.00 , while revenue for the quarter reached $17.38m .
Earnings released on 29 Apr 2025
EPS came in at -$0.22 , while revenue for the quarter reached $15.52m .
Earnings released on 13 Dec 2024
EPS came in at -$0.21 , while revenue for the quarter reached $14.88m .
Earnings released on 30 Aug 2024
EPS came in at $0.00 , while revenue for the quarter reached $16.69m .
Earnings released on 23 May 2024
EPS came in at $0.00 , while revenue for the quarter reached $17.04m .
Earnings released on 1 Apr 2024
EPS came in at -$0.21 falling short of the estimated $2.10 by -109.89%, while revenue for the quarter reached $20.35m , missing expectations by -79.97%.
Earnings released on 2 Jan 2024
EPS came in at $0.05 falling short of the estimated $1.38 by -96.38%, while revenue for the quarter reached $19.13m , missing expectations by -81.12%.
Earnings released on 31 Aug 2023
EPS came in at $0.03 falling short of the estimated $0.05 by -40.00%, while revenue for the quarter reached $27.73m .
Earnings released on 15 May 2023
EPS came in at $0.01 falling short of the estimated $0.04 by -75.00%, while revenue for the quarter reached $29.59m .
Earnings released on 31 Mar 2023
EPS came in at $0.05 , while revenue for the quarter reached $30.62m .
Earnings released on 15 Nov 2022
EPS came in at $0.05 falling short of the estimated $0.32 by -84.38%, while revenue for the quarter reached $28.34m .
Earnings released on 15 Aug 2022
EPS came in at $0.10 falling short of the estimated $0.26 by -61.54%, while revenue for the quarter reached $27.28m , missing expectations by -72.56%.
Earnings released on 16 May 2022
EPS came in at $0.11 falling short of the estimated $0.24 by -54.17%, while revenue for the quarter reached $27.26m , missing expectations by -68.75%.
Earnings released on 6 Apr 2022
EPS came in at -$0.02 falling short of the estimated $0.14 by -114.29%, while revenue for the quarter reached $25.61m .
Earnings released on 15 Nov 2021
EPS came in at -$0.01 falling short of the estimated $0.15 by -106.67%, while revenue for the quarter reached $19.13m .
Earnings released on 16 Aug 2021
EPS came in at $0.12 falling short of the estimated $0.14 by -14.29%, while revenue for the quarter reached $13.84m .
INCR Stock Performance
Access detailed INCR performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
